These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9533640)

  • 1. Effects of cholecystokinin-receptor agonists on cortical 5-HT release in guinea pigs on the X-maze.
    Rex A; Fink H
    Peptides; 1998; 19(3):519-26. PubMed ID: 9533640
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of BOC-CCK-4 and L 365.260 on cortical 5-HT release in guinea-pigs on exposure to the elevated plus maze.
    Rex A; Fink H; Marsden CA
    Neuropharmacology; 1994; 33(3-4):559-65. PubMed ID: 7527129
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cortical 5-HT-CCK interactions and anxiety-related behaviour of guinea-pigs: a microdialysis study.
    Rex A; Marsden CA; Fink H
    Neurosci Lett; 1997 Jun; 228(2):79-82. PubMed ID: 9209103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cholecystokinin-induced anxiety in rats: relevance of pre-experimental stress and seasonal variations.
    Kõks S; Männistö PT; Bourin M; Shlik J; Vasar V; Vasar E
    J Psychiatry Neurosci; 2000 Jan; 25(1):33-42. PubMed ID: 10721682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of diazepam on cortical 5-HT release and behaviour in the guinea-pig on exposure to the elevated plus maze.
    Rex A; Marsden CA; Fink H
    Psychopharmacology (Berl); 1993; 110(4):490-6. PubMed ID: 7532862
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Major biological actions of CCK--a critical evaluation of research findings.
    Fink H; Rex A; Voits M; Voigt JP
    Exp Brain Res; 1998 Nov; 123(1-2):77-83. PubMed ID: 9835394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anxiety but not arousal increases 5-hydroxytryptamine release in the rat ventral hippocampus in vivo.
    Rex A; Voigt JP; Fink H
    Eur J Neurosci; 2005 Sep; 22(5):1185-9. PubMed ID: 16176361
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid antagonist naloxone potentiates anxiogenic-like action of cholecystokinin agonists in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Volke V; Ustav M; Männistö PT; Bourin M; Vasar E
    Neuropeptides; 1998 Jun; 32(3):235-40. PubMed ID: 10189057
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Study of induced effects by selective CCKB agonists cholecystokinin in the nociception and behavior in rodents].
    Dauge V; Derrien M; Durieux C; Noble F; Corringer PJ; Roques BP
    Therapie; 1992 Nov; 47(6):531-9. PubMed ID: 1301645
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BOC-CCK-4, CCK(B)receptor agonist, antagonizes anxiolytic-like action of morphine in elevated plus-maze.
    Kõks S; Soosaar A; Võikar V; Bourin M; Vasar E
    Neuropeptides; 1999 Feb; 33(1):63-9. PubMed ID: 10657473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of 5 -HT1D receptors in cortical extracellular 5-HT release in guinea-pigs on exposure to the elevated plus maze.
    Rex A; Fink H; Skingle M; Marsden CA
    J Psychopharmacol; 1996 Jan; 10(3):219-24. PubMed ID: 22302948
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of cholecystokinin-A and cholecystokinin-B receptors in anxiety.
    Hernandez-Gómez AM; Aguilar-Roblero R; Pérez de la Mora M
    Amino Acids; 2002; 23(1-3):283-90. PubMed ID: 12373548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased CCK(B) receptor binding in rat amygdala in animals demonstrating greater anxiety-like behavior.
    Wunderlich GR; Raymond R; DeSousa NJ; Nobrega JN; Vaccarino FJ
    Psychopharmacology (Berl); 2002 Nov; 164(2):193-9. PubMed ID: 12404082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW; Holladay MW; Barrett RW; Wolfram CA; Miller TR; Witte D; Kerwin JF; Wagenaar F; Nadzan AM
    Mol Pharmacol; 1989 Dec; 36(6):881-6. PubMed ID: 2601685
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin and cholecystokinin mediate nutrient-induced segmentation in guinea pig small intestine.
    Ellis M; Chambers JD; Gwynne RM; Bornstein JC
    Am J Physiol Gastrointest Liver Physiol; 2013 Apr; 304(8):G749-61. PubMed ID: 23392236
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anxiety-related behaviors in cholecystokinin-A, B, and AB receptor gene knockout mice in the plus-maze.
    Miyasaka K; Kobayashi S; Ohta M; Kanai S; Yoshida Y; Nagata A; Matsui T; Noda T; Takiguchi S; Takata Y; Kawanami T; Funakoshi A
    Neurosci Lett; 2002 Dec; 335(2):115-8. PubMed ID: 12459512
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rats with anxious or non-anxious type of exploratory behaviour differ in their brain CCK-8 and benzodiazepine receptor characteristics.
    Harro J; Kiivet RA; Lang A; Vasar E
    Behav Brain Res; 1990 Jun; 39(1):63-71. PubMed ID: 2167692
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of strain difference in behavior to Cholecystokinin (CCK) receptor mediated drugs in PVG hooded and Sprague-Dawley rats using elevated plus-maze test apparatus.
    Farook JM; Zhu YZ; Wang Q; Moochhala SM; Lee L; Wong PT
    Neurosci Lett; 2004 Apr; 358(3):215-9. PubMed ID: 15039119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of memory, reinforcement and anxiety parameters by intra-amygdala injection of cholecystokinin-fragments Boc-CCK-4 and CCK-8s.
    Huston JP; Schildein S; Gerhardt P; Privou C; Fink H; Hasenöhrl RU
    Peptides; 1998; 19(1):27-37. PubMed ID: 9437734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure-based design of new constrained cyclic agonists of the cholecystokinin CCK-B receptor.
    Blommaert AG; Dhôtel H; Ducos B; Durieux C; Goudreau N; Bado A; Garbay C; Roques BP
    J Med Chem; 1997 Feb; 40(5):647-58. PubMed ID: 9057851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.